HCA Healthcare (HCA)
(Delayed Data from NYSE)
$314.45 USD
+4.39 (1.42%)
Updated May 7, 2024 04:00 PM ET
After-Market: $314.49 +0.04 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$314.45 USD
+4.39 (1.42%)
Updated May 7, 2024 04:00 PM ET
After-Market: $314.49 +0.04 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Zacks News
Tenet Healthcare (THC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is It Worth Investing in HCA (HCA) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in HCA (HCA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Ahead of HCA (HCA) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of HCA (HCA) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Should You Buy HCA Healthcare (HCA) Ahead of Q1 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) first-quarter results are likely to reflect increased admissions and patient days.
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Why HCA Healthcare (HCA) Outpaced the Stock Market Today
by Zacks Equity Research
In the closing of the recent trading day, HCA Healthcare (HCA) stood at $310.31, denoting a +1.7% change from the preceding trading day.
Should You Buy Encompass Health (EHC) Ahead of Q1 Earnings?
by Zacks Equity Research
Encompass Health's (EHC) Q1 results are likely to benefit on the back of growing patient volumes and commendable expansion initiatives.
Will Acute Care Unit Aid Universal Health's (UHS) Q1 Earnings?
by Zacks Equity Research
Universal Health's (UHS) Q1 results are expected to be aided by growing patient volumes and surgical cases, partly offset by increased expenses.
HCA Healthcare (HCA) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
HCA (HCA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings
by Nalak Das
We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are: HCA, UHS, LH, EW, PODD.
Here's Why HCA Healthcare (HCA) Fell More Than Broader Market
by Zacks Equity Research
In the latest trading session, HCA Healthcare (HCA) closed at $311.03, marking a -0.91% move from the previous day.
Are Medical Stocks Lagging HCA Healthcare (HCA) This Year?
by Zacks Equity Research
Here is how HCA Healthcare (HCA) and Addus HomeCare (ADUS) have performed compared to their sector so far this year.
Here's Why HCA Healthcare (HCA) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
5 Safe Stocks to Buy as Severe Volatility Grips Wall Street
by Nalak Das
We have narrowed our search to five stocks from defensive sectors to safeguard one's portfolio. These are: AWK, ATO, CELH, HCA, TAP.
HCA Healthcare (HCA) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
In the latest trading session, HCA Healthcare (HCA) closed at $327.25, marking a -0.16% move from the previous day.
4 Sector ETFs & Stocks to Benefit From Hot Inflation
by Sanghamitra Saha
U.S. inflation jumped in March, surpassing expectations primarily due to higher petrol and shelter costs, dashing hopes of a June interest rate cut by the Fed.
Market Jitters: 2 Top Ranked Stocks for Defensive Positioning
by Ethan Feller
With the jump in inflation and rise in interest rate uncertainty investors may want to consider defensive stocks
Why HCA Healthcare (HCA) is a Smart Addition to Your Portfolio
by Zacks Equity Research
HCA Healthcare (HCA) remains well-poised for growth on growing patient volumes, buyouts, effective telehealth services and a notable financial stand.
New to Investing? This 1 Medical Stock Could Be the Perfect Starting Point
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Here is What to Know Beyond Why HCA Healthcare, Inc. (HCA) is a Trending Stock
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to HCA (HCA). This makes it worthwhile to examine what the stock has in store.
3 Sector ETFs & Stocks to Bet on March Jobs Data
by Sanghamitra Saha
The U.S. economy added 303, 000 jobs last month. That data breezed past expectations for 205, 000 job gains, according to FactSet consensus estimates, as quoted on CNBC.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should Value Investors Buy HCA Healthcare (HCA) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
HCA Healthcare (HCA) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
In the closing of the recent trading day, HCA Healthcare (HCA) stood at $328.80, denoting a +1.12% change from the preceding trading day.
Acadia (ACHC) and Uber Health to Enhance Patient Access
by Zacks Equity Research
Acadia (ACHC) partners with Uber Health to ensure timely access to addiction treatment, breaking down transportation barriers for patients.